BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4902019)

  • 1. The effects of propranolol in essential circulatory hyperkinesis.
    Török E; Matos L; Rausch J; Simonyi J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):246-52. PubMed ID: 4902019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta receptor blocking agents in hypercirculatory syndromes and in high performance athletes].
    Gattenlöhner W; Schneider KW; Rost R
    Med Welt; 1969 Oct; 42():2298-306. PubMed ID: 4901510
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of beta-receptor blocking agents propranolol and practolol on ST-T changes in neurocirculatory asthenia.
    Wolf E; Braun K; Stern S
    Br Heart J; 1974 Sep; 36(9):872-9. PubMed ID: 4425601
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamics in patients suffering from hyperkinetic cardiac syndromes and in normal persons under psychological stress before and after treatment with propranolol (author's transl)].
    Magometschnigg D; Bonelli J; Kaik G
    Z Kardiol; 1979 Mar; 68(3):183-8. PubMed ID: 220809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a ganglionic blocking agent (chlorisondamine) on electrocardiogram, physical working capacity and hemodynamics in patients with vasoregulatory asthenia.
    Arvedson O; Furberg C; Linderholm H
    Acta Med Scand Suppl; 1967; 472():36-53. PubMed ID: 5231572
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term propranolol therapy in essential circulatory hyperkinesis.
    Török E; Bajkay G; Gulyás A; Istvánffy M; Matos L
    Int J Clin Pharmacol; 1972 Nov; 6(4):364-74. PubMed ID: 4629827
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemodynamic effects of propranolol in chronic lung diseases.
    Lockhart A; Schrijen F; Salmon D; Andrada L; Peslin R
    Clin Sci; 1967 Aug; 33(1):101-10. PubMed ID: 6059290
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of propranolol on circulatory hemodynamics of patients with coronary heart failure in the light of polycardiographic examination.
    Mazurowa A; Tracz W
    Pol Med J; 1970; 9(4):827-34. PubMed ID: 5477489
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-adrenergic blockade in the diagnosis of the ST-T complex in electrocardiography].
    Wiecko W; Szabelski R
    Wiad Lek; 1974 Jul; 27(14):1245-51. PubMed ID: 4417492
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of psycho-neurotic conversion reactions with pindolol. (Effect on cardio-vascular response to exercise).
    Kelesidis G; Hagis P; Samaras C
    Indian Heart J; 1972 Jun; 24():Suppl 1:238-43. PubMed ID: 4147280
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation.
    Dufour R; Scazziga B; Schelling JL
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):145-7. PubMed ID: 4395480
    [No Abstract]   [Full Text] [Related]  

  • 12. The hemodynamic effects of beta-adrenergic blockade in patients with neurocirculatory asthenia.
    Schweitzer P; Pivonka M; Gregorová J
    Cardiologia (Basel); 1968; 52(5):246-51. PubMed ID: 5713275
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperkinetic heart syndrome].
    Lohmöller G; Lydtin H
    Fortschr Med; 1971 Aug; 89(22):864-7. PubMed ID: 4403734
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of the orthostasis syndrome in children and adolescents].
    Menner K
    Arch Kreislaufforsch; 1970; 61(1):27-63. PubMed ID: 4394141
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of the propranolol test in ambulatory cardiological diagnosis].
    Einaudi G; Pecchiura G
    Minerva Med; 1973 Jul; 64(5):2669-79. PubMed ID: 4790888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of the sympathetic nervous system in functional cardiac disorders and the action of beta-adrenergic sympathetic blocking agents].
    Lichtig E; Georgescu M; Păun R
    Med Interna (Bucur); 1968 Feb; 20(2):163-74. PubMed ID: 5668963
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of age on the response to propranolol.
    Conway J
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):148-50. PubMed ID: 4924320
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of beta adrenergic receptor blockaders in industrial workers with neurocirculatory asthenia of the hypertensive type].
    Maziĭ SA; Senik EA; Turashvili GA; Zisel'man SB; Kazarian AB
    Sov Med; 1988; (7):96-9. PubMed ID: 3067385
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography].
    Józan M; Tarján J; Wágner G; Rostás L; Lascsik L; Kovács S; Parti G
    Orv Hetil; 1981 Oct; 122(41):2547-8. PubMed ID: 6119668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Exertion insufficiency during beta blocker therapy in the hyperkinetic heart syndrome].
    Niehues B; Hermanns L; Kortenbruck R; Behrenbeck DW; Hilger HH
    Verh Dtsch Ges Inn Med; 1978; (84):736-9. PubMed ID: 742112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.